Early adopters share first-hand experience with Cryoimmunostaining™ technology Halle (Saale), November 2025 – After breaking new ground last year by featuring Cryoimmunostaining™ in the official scientific programme for the first time, the 2025 Seminar on Clinical...
New data confirms routine utility of Cryoimmunostaining™ for effusion and FNA samples Ljubljana, October 2025 – New clinical data on multiplex Cryoimmunostaining™ took centre stage at an international science conference in Ljubljana, Slovenia, where digital cytology...
X-ZELL previews world’s first expert-vetted multiplex panels for cytopathology Florence , May 2025 – X-ZELL is proud to announce the new Cryophore™ range of standardized multiplex antibody panels, developed in close collaboration with leading experts and WHO guideline...
German cytology conference marks historic milestone for multiplex immunostaining Halle, November 2024 — A forward-looking panel discussion on the future of multiplex immunostaining took centre stage at the 2024 Seminar on Clinical Cytology in Pulmonology in Halle,...
X-ZELL outperforms traditional immunostaining in German landmark study Leipzig, July 2024 – New research from Germany has shown that X-ZELL technology could dramatically reduce the number of inconclusive cancer diagnoses from minimally invasive sample material. During...
X-ZELL launches Global Technology Trial Leipzig, June 2024 – To celebrate the 45th anniversary of the European Congress of Cytology (ECC) in Leipzig, Germany, X-ZELL has announced the launch of an international Technology Trial program. X-ZELL Founder & CEO, Dr...
